Rural Health
Resources by Topic: Prescription drug misuse
Comparing the Care, Distance Traveled, and Health Workforce Clinician Mix for Rural and Urban Commercially Insured Enrollees With Opioid Use Disorder
Examines characteristics of opioid treatment in rural and urban communities across the United States. Utilizes 2019 commercial claims data from the Health Care Cost Institute (HCCI) to analyze rural versus urban differences in opioid use disorder and overdose diagnoses, healthcare utilization, healthcare visits by clinician type, average distance traveled to utilize healthcare, and location of received care.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Lisa A. Garberson, Janessa M. Graves
Date: 04/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
Examines characteristics of opioid treatment in rural and urban communities across the United States. Utilizes 2019 commercial claims data from the Health Care Cost Institute (HCCI) to analyze rural versus urban differences in opioid use disorder and overdose diagnoses, healthcare utilization, healthcare visits by clinician type, average distance traveled to utilize healthcare, and location of received care.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Lisa A. Garberson, Janessa M. Graves
Date: 04/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
Rural-Urban Variation in Opioid Use Disorder Treatment Access among Commercially Insured Children and Adolescents
Details a study on the geographic factors that affect access to treatment for youth and adolescents, aged 0-17, with an opioid use disorder (OUD) and covered by commercial insurance in 2019. Discusses the effects of rurality, provider type, travel burden, and residing in a county without a clinician with a DEA waiver, among other measures.
Author(s): C. Holly A. Andrilla, Lisa A. Garberson, Sara C. Woolcock, Janessa M. Graves
Date: 04/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
Details a study on the geographic factors that affect access to treatment for youth and adolescents, aged 0-17, with an opioid use disorder (OUD) and covered by commercial insurance in 2019. Discusses the effects of rurality, provider type, travel burden, and residing in a county without a clinician with a DEA waiver, among other measures.
Author(s): C. Holly A. Andrilla, Lisa A. Garberson, Sara C. Woolcock, Janessa M. Graves
Date: 04/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
Comparing the Care and Distance Traveled by Rural and Urban Children and Adolescents with Medicaid Insurance and Opioid Use Disorder
Presents a study on the geographic factors that affect access to treatment for youth and adolescents, aged 0-17, with an opioid use disorder (OUD) and enrolled in Medicaid in 2019. Discusses the effects of rurality, travel burden, and residing in a county without a clinician with a DEA waiver, among other measures.
Author(s): Janessa M. Graves, Lisa A. Garberson, Sara C. Woolcock, C. Holly A. Andrilla
Date: 04/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
Presents a study on the geographic factors that affect access to treatment for youth and adolescents, aged 0-17, with an opioid use disorder (OUD) and enrolled in Medicaid in 2019. Discusses the effects of rurality, travel burden, and residing in a county without a clinician with a DEA waiver, among other measures.
Author(s): Janessa M. Graves, Lisa A. Garberson, Sara C. Woolcock, C. Holly A. Andrilla
Date: 04/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
Hepatitis C Virus Transmission among People Who Inject Drugs in Rural United States: Mathematical Modeling Study Using Stochastic Agent-Based Network Simulation
Presents a study exploring a network simulation model of hepatitis C virus (HCV) transmission among rural people who inject drugs (PWID). Breaks down data by participant characteristics, such as age, sex, and HCV antibody positivity, among others, and network characteristics, such as size and percentage of PWID who are HCV positive, among others.
Author(s): Lin Zhu, Jennifer R Havens, Abby E Rudolph, et al.
Citation: American Journal of Epidemiology, 195(4), 937-947
Date: 04/2026
view details
Presents a study exploring a network simulation model of hepatitis C virus (HCV) transmission among rural people who inject drugs (PWID). Breaks down data by participant characteristics, such as age, sex, and HCV antibody positivity, among others, and network characteristics, such as size and percentage of PWID who are HCV positive, among others.
Author(s): Lin Zhu, Jennifer R Havens, Abby E Rudolph, et al.
Citation: American Journal of Epidemiology, 195(4), 937-947
Date: 04/2026
view details
Virginia's Plan for Well-Being: 2025-2029
Offers a data and community-driven roadmap to improve health outcomes and ensure that all Virginians live in conditions that allow them to thrive. Includes statistics on social determinants of health, infant mortality, firearm-related deaths and injury, obesity, mental health, substance use disorder, and housing. Features a county-level map showing rates of drug overdose deaths as of 2021. Mentions rural throughout.
Date: 04/2026
Sponsoring organization: Virginia Department of Health
view details
Offers a data and community-driven roadmap to improve health outcomes and ensure that all Virginians live in conditions that allow them to thrive. Includes statistics on social determinants of health, infant mortality, firearm-related deaths and injury, obesity, mental health, substance use disorder, and housing. Features a county-level map showing rates of drug overdose deaths as of 2021. Mentions rural throughout.
Date: 04/2026
Sponsoring organization: Virginia Department of Health
view details
Post-Hospital Access to Preferred and High-Quality Skilled Nursing Facilities for Patients With Opioid Use Disorder
Examines access to preferred and high-quality skilled nursing facilities (SNFs) among Medicare beneficiaries with opioid use disorder (OUD). Utilizes 2017-2021 Medicare inpatient claims data to analyze 6,490,593 patients with OUD and their likelihood to enter preferred and high-quality SNFs according to patient demographics and urbanicity of metro, micro, small town, or rural.
Author(s): Talia S. Benheim, Momotazur Rahman, Andrew R. Zullo, et al.
Citation: Health Services Research, 61(2), e70110
Date: 04/2026
view details
Examines access to preferred and high-quality skilled nursing facilities (SNFs) among Medicare beneficiaries with opioid use disorder (OUD). Utilizes 2017-2021 Medicare inpatient claims data to analyze 6,490,593 patients with OUD and their likelihood to enter preferred and high-quality SNFs according to patient demographics and urbanicity of metro, micro, small town, or rural.
Author(s): Talia S. Benheim, Momotazur Rahman, Andrew R. Zullo, et al.
Citation: Health Services Research, 61(2), e70110
Date: 04/2026
view details
Expanding Access to Low-Barrier Opioid Use Disorder Treatment in Non-Traditional Settings: Washington's Opioid Treatment Network
Presents a study exploring use of opioid treatment networks to provide low-barrier access to medications to treat opioid use disorder (MOUD) in Washington State. Compares rates of buprenorohine utilization of individuals within and outside of the network and by rural-urban residence.
Author(s): Shay M. Daily, Sharon Reif, Elizabeth Speaker, et al.
Citation: Journal of Rural Health, 42(2), e70139
Date: 03/2026
view details
Presents a study exploring use of opioid treatment networks to provide low-barrier access to medications to treat opioid use disorder (MOUD) in Washington State. Compares rates of buprenorohine utilization of individuals within and outside of the network and by rural-urban residence.
Author(s): Shay M. Daily, Sharon Reif, Elizabeth Speaker, et al.
Citation: Journal of Rural Health, 42(2), e70139
Date: 03/2026
view details
Brief Prescribing Support and Buprenorphine Adoption in Rural Primary Care: A Cluster Randomized Clinical Trial
Explores the efficacy of a brief support program on rural primary care providers willingness to prescribe buprenorphine for opioid use disorder (OUD). Breaks down the support program modules aimed at educating providers about buprenorphine-based treatment and prescribing practices. Highlights post-intervention changes in prescribing and treatment outcomes.
Author(s): Berkeley Franz, Lindsay Y. Dhanani, Daniel Brook, et al.
Citation: JAMA Network Open, 9(3), e263050
Date: 03/2026
view details
Explores the efficacy of a brief support program on rural primary care providers willingness to prescribe buprenorphine for opioid use disorder (OUD). Breaks down the support program modules aimed at educating providers about buprenorphine-based treatment and prescribing practices. Highlights post-intervention changes in prescribing and treatment outcomes.
Author(s): Berkeley Franz, Lindsay Y. Dhanani, Daniel Brook, et al.
Citation: JAMA Network Open, 9(3), e263050
Date: 03/2026
view details
Resilience to Stigma in Medical, Social, and Employment Contexts among People Who Inject Drugs in Rural Ohio: Adapting the 10-Item Connor-Davidson Resilience Scale
Explores the role stigma related to drug use and HIV plays in the lives of people who inject drugs (PWID) and aims to build resilience in medical, social, and employment contexts for PWID in rural Appalachian Ohio. Presents results from a series of interviews and a qualitative survey placing participants on the Connor-Davidson Resilience Scale.
Author(s): Madison N. Enderle, Rebecca H. Neiberg, Stacy M. Endres-Dighe, et al.
Citation: AIDS and Behavior, 30, 894-906
Date: 03/2026
view details
Explores the role stigma related to drug use and HIV plays in the lives of people who inject drugs (PWID) and aims to build resilience in medical, social, and employment contexts for PWID in rural Appalachian Ohio. Presents results from a series of interviews and a qualitative survey placing participants on the Connor-Davidson Resilience Scale.
Author(s): Madison N. Enderle, Rebecca H. Neiberg, Stacy M. Endres-Dighe, et al.
Citation: AIDS and Behavior, 30, 894-906
Date: 03/2026
view details
Comparing the Care and Distance Traveled by Rural and Urban Medicaid Beneficiaries With Opioid Use Disorder
Results of a study describing the treatment for rural and urban Medicaid beneficiaries with opioid use disorder in 2019. Features demographics and statistics on number of visits and travel time and distance, with breakdowns by 5 levels of population density.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Lisa A. Garberson, Janessa M. Graves
Date: 03/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
Results of a study describing the treatment for rural and urban Medicaid beneficiaries with opioid use disorder in 2019. Features demographics and statistics on number of visits and travel time and distance, with breakdowns by 5 levels of population density.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Lisa A. Garberson, Janessa M. Graves
Date: 03/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details